Showing results (71-80 of 581) with videos related to
Sort By:
Pageof 59
Stem Cells (Dayton, Ohio)|October 1, 1993
Autografting for patients with chronic myeloid leukemia--the Hammersmith experienceT Mughal, C Hoyle, J M GoldmanBone Marrow Transplantation|April 1, 1996
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT)N Schmitz, A Gratwohl, J M GoldmanLeukemia|November 1, 1993
The abnormal p53 proteins expressed in CML cell lines are non-functionalS Bi, F Lanza, J M GoldmanCancer Research|January 15, 1994
The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesisS Bi, F Lanza, J M GoldmanBone Marrow Transplantation|June 1, 1994
World Marrow Donor Association: a progress reportJ M Goldman, S Cleaver, P WarrenExperimental Hematology|March 1, 1986
Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cellsT Robak, R Hast, J M GoldmanBlood|November 15, 1990
Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemiaS Mackinnon, J M Hows, J M GoldmanBritish Journal of Haematology|July 1, 1981
Autologous neutrophils inhibit production of colony stimulating activity by normal human lymphocytesA Lutynski, K H Th'ng, J M GoldmanBritish Journal of Haematology|March 1, 1994
A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemiaF Lin, J M Goldman, N C CrossBlood|April 15, 1995
Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemiaH Sill, J M Goldman, N C CrossPageof 59